No Cover Image

Journal article 93 views 9 downloads

Lymphoedema Development Following a Cancer Diagnosis: An Anonymised Data Linkage Study in Wales, United Kingdom

Ioan Humphreys Orcid Logo, Alan Watkins Orcid Logo, Ashley Akbari Orcid Logo, Rowena Griffiths, Marie Gabe‐Walters, Melanie Thomas Orcid Logo, Cheryl Pike, Angela Williams, Thomas Dobbs, John Gibson, Iain Whitaker, Hayley Hutchings Orcid Logo

International Wound Journal, Volume: 22, Issue: 4, Start page: e70331

Swansea University Authors: Ioan Humphreys Orcid Logo, Alan Watkins Orcid Logo, Ashley Akbari Orcid Logo, Angela Williams, Thomas Dobbs, Iain Whitaker, Hayley Hutchings Orcid Logo

  • 69157.VOR.pdf

    PDF | Version of Record

    © 2025 The Author(s). International Wound Journal published by Medicalhelplines.com Inc and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License (CC BY).

    Download (643.69KB)

Check full text

DOI (Published version): 10.1111/iwj.70331

Abstract

This observational cohort study explored lymphoedema development following a cancer diagnosis and whether demographic factors impacted the time to lymphoedema development. We identified cases through the Secure Anonymised Information Linkage (SAIL) Databank. We used cancer diagnostic codes to identi...

Full description

Published in: International Wound Journal
ISSN: 1742-4801 1742-481X
Published: Wiley 2025
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa69157
Abstract: This observational cohort study explored lymphoedema development following a cancer diagnosis and whether demographic factors impacted the time to lymphoedema development. We identified cases through the Secure Anonymised Information Linkage (SAIL) Databank. We used cancer diagnostic codes to identify a cohort of six broad cancer ‘types’. We independently used lymphoedema diagnostic codes to identify a cohort who developed lymphoedema. We linked these two cohorts to develop a single cohort of cases and describe the number of cases who went on to develop lymphoedema after a cancer diagnosis, and the time to lymphoedema diagnosis. We used Cox regression models to calculate hazard ratios and produced survival curves to explore whether pre-defined factors (gender, age, deprivation, cancer type) had any impact on time to lymphoedema development. We identified 7538 cases of lymphoedema development after a cancer diagnosis, relating to 7279 people. There was considerable variation in the time to diagnosis, with a mean and standard deviation of 483.3 (701.8) days. Cancer type was the single most important factor in explaining time to lymphoedema diagnosis. Time to lymphoedema was shortest in breast cancer. A large number of breast cancer cases have undergone surgery, and this may account for the earlier development of lymphoedema. Consideration should be made of risk factors for lymphoedema development in order to allow for more targeted treatment plans that could improve health-related quality of life for patients.
Keywords: cancer, diagnosis, linked routine data, lymphoedema, risk factors
College: Faculty of Medicine, Health and Life Sciences
Funders: This project has been commissioned by the Lymphoedema Network Wales as part of NHS Wales, with direct funding from the NHS to support its activities.
Issue: 4
Start Page: e70331